Amgen Trims 2012 EPS Estimate, Citing R&D Tax Credit Delay

09.01.2013 - Amgen, the world's largest biotechnology company, on Tuesday lowered its outlook for 2012 earnings per share by 10 cents, citing a delay in the impact of a U.S. tax credit for...